{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-028774","form_type":"8-K","ticker":"VXRT","cik":"0000072444","company_name":"Vaxart, Inc.","filed_at":"2023-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.830618+00:00","generated_at":"2026-06-09T17:34:58.633809+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Vaxart amends bylaws: reduces stockholder quorum to one-third, updates advance notice","bullets":["Board adopted amended bylaws effective Oct 18, 2023 to conform to DGCL amendments.","Quorum reduced from majority to at least one-third of outstanding voting shares.","Advance notice provisions updated per Rule 14a-19 universal proxy rules.","Stockholder notices for nominations/business proposals must now be in writing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-028774","json":"https://secwatch.observer/filing/0001437749-23-028774.json","markdown":"https://secwatch.observer/filing/0001437749-23-028774.md","text":"https://secwatch.observer/filing/0001437749-23-028774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72444/000143774923028774/0001437749-23-028774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72444/000143774923028774/vxrt20231020_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T17:34:58.633809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"37dd24284b4f24d663ddedc265baec064f66df67","claim":"Vaxart, Inc.: Amended and restated bylaws to conform to recent DGCL amendments, reduce stockholder meeting quorum from majority to at least one-third, update advance notice provisions for nominations and other business, and make other clarifying and procedural changes (effective 2023-10-18).","evidence_excerpt":"On October 18, 2023, the Board of Directors (the “Board”) of Vaxart, Inc. (the “Company”) approved and adopted the Amended and Restated Bylaws of the Company (the “Bylaws”), effective [immediately], to update the bylaws to conform certain provisions to the Delaware General Corporation Law (the “DGCL”) in light of, among other things, recent amendments to the DGCL, to make clarifying changes, and to effect certain other changes regarding internal procedural matters, including the following changes","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923028774/0001437749-23-028774-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-10-18"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}